Steven J. Romano - Jan 2, 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Signature
/s/ Rhonda Hellums, Attorney-in-Fact
Stock symbol
SLN
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/6/2025, 04:15 PM
Previous filing
Sep 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN Employee Share Option (Right to Buy) Award $0 +285K $0.00 285K Jan 2, 2025 Ordinary Shares 285K $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.